PERRIGO Co plcPRGOEarnings & Financial Report
NYSE · Health Care · Pharmaceutical Preparations
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| The Vanguard Group | 11.07% | 15.0M | — | 2024-02-13 |
| BlackRock, Inc. | 9.80% | 13.3M | — | 2024-01-24 |
| OF ABOVE PERSONS | 5.10% | 7.0M | — | 2024-10-31 |
| NOS. OF ABOVE PERSONS | — | — | — | 2024-02-13 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-02 | Bezerra Eduardo Guarita | EVP & Chief Financial Officer | Option exercise | 6.4K | $10.85 | $69.1K |
| 2026-04-02 | Lockwood-Taylor Patrick | CEO | Option exercise | 17.8K | $10.85 | $193.5K |
| 2026-04-02 | Robert Willis | EVP & CHRO | Option exercise | 2.1K | $10.85 | $22.5K |
| 2026-03-06 | Robert Willis | EVP & CHRO | Option exercise | 2.7K | $10.72 | $29.4K |
| 2026-03-06 | Robert Willis | EVP & CHRO | Option exercise | 1.8K | $10.72 | $18.8K |
| 2026-03-06 | Robert Willis | EVP & CHRO | Grant | 8.0K | $10.72 | $86.0K |
| 2026-03-06 | Lockwood-Taylor Patrick | CEO | Option exercise | 11.7K | $10.72 | $125.7K |
| 2026-03-06 | Lockwood-Taylor Patrick | CEO | Grant | 13.8K | $10.72 | $148.4K |
| 2026-03-06 | Bezerra Eduardo Guarita | EVP & Chief Financial Officer | Option exercise | 4.9K | $10.72 | $52.2K |
| 2026-03-06 | Bezerra Eduardo Guarita | EVP & Chief Financial Officer | Option exercise | 5.0K | $10.72 | $53.4K |
1–10 of 13
Page 1 / 2